These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22612675)

  • 1. Discovery bioanalysis. Foreward.
    Shou WZ
    Bioanalysis; 2012 May; 4(9):983-4. PubMed ID: 22612675
    [No Abstract]   [Full Text] [Related]  

  • 2. High-resolution mass spectrometry will dramatically change our drug-discovery bioanalysis procedures.
    Korfmacher W
    Bioanalysis; 2011 Jun; 3(11):1169-71. PubMed ID: 21649491
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative high-throughput analysis of drugs in biological matrices by mass spectrometry.
    Hopfgartner G; Bourgogne E
    Mass Spectrom Rev; 2003; 22(3):195-214. PubMed ID: 12838545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo pharmacokinetic screening in cassette dosing experiments; the use of on-line Pprospekt liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry technology in drug discovery.
    Beaudry F; Le Blanc JC; Coutu M; Brown NK
    Rapid Commun Mass Spectrom; 1998; 12(17):1216-22. PubMed ID: 9737010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent development in software and automation tools for high-throughput discovery bioanalysis.
    Shou WZ; Zhang J
    Bioanalysis; 2012 May; 4(9):1097-109. PubMed ID: 22612689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing need for bioanalysis during drug development.
    Srinivas NR
    Biomed Chromatogr; 2008 Mar; 22(3):235-43. PubMed ID: 17939165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel LC-MS approach for the detection of metabolites in DMPK studies.
    Plumb RS; Mather J; Little D; Rainville PD; Twohig M; Harland G; Kenny DJ; Nicholson JK; Wilson ID; Kass IJ
    Bioanalysis; 2010 Oct; 2(10):1767-78. PubMed ID: 21083328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection Technologies. Ambient mass spectrometry.
    Cooks RG; Ouyang Z; Takats Z; Wiseman JM
    Science; 2006 Mar; 311(5767):1566-70. PubMed ID: 16543450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug bioanalysis and biomarker discovery at the Commissariat à l'énergie atomique et aux énergies alternatives.
    Ezan E; Becher F; Benech H; Fenaille F; Junot C; Mabondzo A; Pruvost A
    Bioanalysis; 2010 Apr; 2(4):713-7. PubMed ID: 21083268
    [No Abstract]   [Full Text] [Related]  

  • 10. Turbulent flow bioanalysis in drug metabolism and pharmacokinetics.
    Rudewicz PJ
    Bioanalysis; 2011 Jul; 3(14):1663-71. PubMed ID: 21756098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioanalysis without sample cleanup or chromatography: the evaluation and initial implementation of direct analysis in real time ionization mass spectrometry for the quantification of drugs in biological matrixes.
    Yu S; Crawford E; Tice J; Musselman B; Wu JT
    Anal Chem; 2009 Jan; 81(1):193-202. PubMed ID: 19117450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: are we all the way there yet?
    Nassar AE; Talaat RE; Kamel AM
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):61-74. PubMed ID: 16445118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capillary electrophoresis-mass spectrometry, an attractive tool for drug bioanalysis and biomarker discovery.
    Servais AC; Crommen J; Fillet M
    Electrophoresis; 2006 Jul; 27(13):2616-29. PubMed ID: 16817163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry imaging in drug development.
    Nilsson A; Goodwin RJ; Shariatgorji M; Vallianatou T; Webborn PJ; Andrén PE
    Anal Chem; 2015 Feb; 87(3):1437-55. PubMed ID: 25526173
    [No Abstract]   [Full Text] [Related]  

  • 15. Current and future trends in the application of HPLC-MS to metabolite-identification studies.
    Castro-Perez JM
    Drug Discov Today; 2007 Mar; 12(5-6):249-56. PubMed ID: 17331890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays.
    Chovan LE; Black-Schaefer C; Dandliker PJ; Lau YY
    Rapid Commun Mass Spectrom; 2004; 18(24):3105-12. PubMed ID: 15565734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix-assisted laser desorption/ionization mass spectrometric imaging of complete rat sections using a triple quadrupole linear ion trap.
    Hopfgartner G; Varesio E; Stoeckli M
    Rapid Commun Mass Spectrom; 2009 Mar; 23(6):733-6. PubMed ID: 19206086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry-based proteomics in preclinical drug discovery.
    Schirle M; Bantscheff M; Kuster B
    Chem Biol; 2012 Jan; 19(1):72-84. PubMed ID: 22284356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
    Srinivas NR
    Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.